News
Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...
Driven Compound Is Winning Over Reviewers, Professionals, and Biohackers BOSTON, MASSACHUSETTS / ACCESS Newswire / July 17, ...
Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...
While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key ...
Partnering with Kellogg Executive Education, the US arm of this global pharmaceutical company is investing in its people to ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Smith Hunter C, Chief Financial Officer of Rhythm Pharmaceuticals( RYTM 0.25%), reported mixed transactions totaling 42,120 ...
The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...
It’s increasingly clear that “payment conservativism” — avoiding paying too much to medical research participants — is the ...
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Texas has pledged public money to research ibogaine, hoping for FDA approval to aid veterans with PTSD and addiction.
Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results